1-[(2R,3R,4S)-4-[Bis(4-methoxyphenyl)phenylmethoxy]tetrahydro-3-hydroxy-2-furanyl]-2,4(1H,3H)-pyrimidinedione

Request For Quotation
1-[(2R,3R,4S)-4-[Bis(4-methoxyphenyl)phenylmethoxy]tetrahydro-3-hydroxy-2-furanyl]-2,4(1H,3H)-pyrimidinedione Suppliers list
Company Name: NewCan Biotech Limited  
Tel: +86-571-86912261 19975279805
Email: sales@newcanbio.com
Company Name: Suzhou Meidi Senuo Pharmaceutical Technology Co., Ltd.  
Tel: 13771642864
Email: snhuyu_2008@126.com
Company Name: TargetMol Chemicals Inc.  
Tel: 15002134094
Email: marketing@targetmol.cn
Company Name: Shanghai meikai technology co., ltd  
Tel: 021-68689288 15300790979
Email: info@mkbio.com.cn
Company Name: TargetMol Chemicals Inc.  
Tel: +1-781-999-5354;
Email: support@targetmol.com

1-[(2R,3R,4S)-4-[Bis(4-methoxyphenyl)phenylmethoxy]tetrahydro-3-hydroxy-2-furanyl]-2,4(1H,3H)-pyrimidinedione manufacturers
1-[(2R,3R,4S)-4-[Bis(4-methoxyphenyl)phenylmethoxy]tetrahydro-3-hydroxy-2-furanyl]-2,4(1H,3H)-pyrimidinedione Basic information
Product Name:1-[(2R,3R,4S)-4-[Bis(4-methoxyphenyl)phenylmethoxy]tetrahydro-3-hydroxy-2-furanyl]-2,4(1H,3H)-pyrimidinedione
Synonyms:1-[(2R,3R,4S)-4-[Bis(4-methoxyphenyl)phenylmethoxy]tetrahydro-3-hydroxy-2-furanyl]-2,4(1H,3H)-pyrimidinedione;1-(3’-O-[4,4’-dimethoxytrityl]-alpha-L-threofuranosyl)uridine;1-{3'-O-[(4",4"'-dimethoxytriphenyl)methyl]-α-L-threofuranosyl}uracil
CAS:325683-90-7
MF:C29H28N2O7
MW:516.54182
EINECS:
Product Categories:
Mol File:325683-90-7.mol
1-[(2R,3R,4S)-4-[Bis(4-methoxyphenyl)phenylmethoxy]tetrahydro-3-hydroxy-2-furanyl]-2,4(1H,3H)-pyrimidinedione Structure
1-[(2R,3R,4S)-4-[Bis(4-methoxyphenyl)phenylmethoxy]tetrahydro-3-hydroxy-2-furanyl]-2,4(1H,3H)-pyrimidinedione Chemical Properties
density 1.37±0.1 g/cm3 (20 ºC 760 Torr)
Safety Information
MSDS Information
1-[(2R,3R,4S)-4-[Bis(4-methoxyphenyl)phenylmethoxy]tetrahydro-3-hydroxy-2-furanyl]-2,4(1H,3H)-pyrimidinedione Usage And Synthesis
Uses1-(3’-O-[4,4’-dimethoxytrityl]-alpha-L-threofuranosyl)uridine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1].
References[1] Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18(23):3373-88. DOI:10.2174/138161212801227005
1-[(2R,3R,4S)-4-[Bis(4-methoxyphenyl)phenylmethoxy]tetrahydro-3-hydroxy-2-furanyl]-2,4(1H,3H)-pyrimidinedione Preparation Products And Raw materials
Tag:1-[(2R,3R,4S)-4-[Bis(4-methoxyphenyl)phenylmethoxy]tetrahydro-3-hydroxy-2-furanyl]-2,4(1H,3H)-pyrimidinedione(325683-90-7) Related Product Information
Uridine Raltitrexed Capecitabine 6-Mercaptopurine Broxuridine 4-Thiouridine